Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
85SFVDuaxawm2VGN
